EBO Stock Overview
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$32.16 |
| 52 Week High | NZ$42.47 |
| 52 Week Low | NZ$30.81 |
| Beta | 0.26 |
| 1 Month Change | 1.74% |
| 3 Month Change | -5.24% |
| 1 Year Change | -22.13% |
| 3 Year Change | 16.95% |
| 5 Year Change | 56.50% |
| Change since IPO | 287.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| EBO | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 1.7% | 2.6% | 0.9% |
| 1Y | -22.1% | -20.9% | 5.7% |
Return vs Industry: EBO underperformed the Australian Healthcare industry which returned -20.9% over the past year.
Return vs Market: EBO underperformed the Australian Market which returned 5.7% over the past year.
Price Volatility
| EBO volatility | |
|---|---|
| EBO Average Weekly Movement | 3.3% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: EBO has not had significant price volatility in the past 3 months.
Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 5,000 | John Cullity | www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
EBOS Group Limited Fundamentals Summary
| EBO fundamental statistics | |
|---|---|
| Market cap | AU$6.26b |
| Earnings (TTM) | AU$257.35m |
| Revenue (TTM) | AU$12.67b |
24.3x
P/E Ratio0.5x
P/S RatioIs EBO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBO income statement (TTM) | |
|---|---|
| Revenue | AU$12.67b |
| Cost of Revenue | AU$11.09b |
| Gross Profit | AU$1.58b |
| Other Expenses | AU$1.33b |
| Earnings | AU$257.35m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 21, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 12.49% |
| Net Profit Margin | 2.03% |
| Debt/Equity Ratio | 62.3% |
How did EBO perform over the long term?
See historical performance and comparison